S. Lumba

Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer.

J. Rasko, T. Becker, W. Chua, 2014, Cancer letters.

Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors

N. Pavlakis, M. Wong, J. Samra, 2016, Neuroendocrinology.

Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence‐based benchmark for cancer care

S. Clarke, S. Kao, N. Zandwijk, 2015, Asia-Pacific journal of clinical oncology.

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)

Adrian Lee, N. Pavlakis, M. Wong, 2016, PloS one.

Efficacy of SBP-101, a polyamine metabolic inhibitor, administered in combination with gemcitabine and nab-paclitaxel, as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma.

A. Hezel, A. Nagrial, T. George, 2022, Journal of Clinical Oncology.